Orchiectomy reduces hepatotumorigenesis of H-ras12V transgenic mice via the MAPK pathway
- 19 October 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 79 (21) , 1974-1980
- https://doi.org/10.1016/j.lfs.2006.06.032
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosisBMC Gastroenterology, 2003
- Sex hormones and liver cancerMolecular and Cellular Endocrinology, 2002
- Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized studyAmerican Journal of Gastroenterology, 2000
- Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial.Journal of Clinical Oncology, 1998
- Phase II study of flutamide in the treatment of hepatocellular carcinomaCancer, 1996
- Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and ThailandMolecular Carcinogenesis, 1993
- HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 1991
- Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous.Proceedings of the National Academy of Sciences, 1989
- Estrogen and Androgen Receptors in Liver: Their Role in Liver Disease and RegenerationSeminars in Liver Disease, 1985
- Sex Hormones and the LiverClinical Science, 1984